CD274 and neoplasm: Immune checkpoint inhibitors are monoclonal antibodies designed to target multiple checkpoint molecules, such as PD-1, CTLA-4, Tim-3, Lag-3, and VISTA, expressed primarily by T cells, as well as PD-L1, the ligand for PD-1, expressed primarily by the tumor or other immune cells [14].